XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Report
- Report Number
- 2024168-2017-03726
- Event Type
- Injury
- Date Received
- April 27, 2017
- Date of Event
- April 4, 2017
- Report Date
- April 27, 2017
- Manufacturer
- AV-TEMECULA-CT
- Product Code
- NIQ
- UDI-DI
- 08717648199271
- PMA / PMN Number
- P110019
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
(B)(4). CONCOMITANT MEDICAL PRODUCTS: GUIDE WIRE: RINATO, GUIDE CATHETER: HYPERION. THE DEVICE WAS NOT RETURNED FOR EVALUATION. A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS, AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED. A REVIEW OF THE LOT HISTORY RECORD IDENTIFIED NO MANUFACTURING NONCONFORMITIES ISSUED TO THE REPORTED LOT THAT WOULD HAVE CONTRIBUTED TO THIS EVENT. THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO THE DESIGN, MANUFACTURE, OR LABELING OF THE DEVICE. THE TENKU RX IS FILED UNDER A SEPARATE MEDWATCH REPORT NUMBER.
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A MODERATELY TORTUOUS, MILDLY CALCIFIED, CONCENTRIC, AND DE NOVO FIRST DIAGONAL ARTERY THAT WAS 90% STENOSED. AN UNSPECIFIED XIENCE ALPINE STENT WAS IMPLANTED IN THE PROXIMAL LEFT ANTERIOR DESCENDING ARTERY WHEN PLAQUE SHIFT OCCURRED AT THE ENTRANCE OF THE FIRST DIAGONAL. A 1.5 X 12 MM RX TENKU WAS BEING USED TO DILATE THE VESSEL WHEN THE BALLOON RUPTURED ON THE FIRST INFLATION AFTER 10 SECONDS AT 6 ATMOSPHERES. A NON-ABBOTT BALLOON WAS SUCCESSFULLY USED TO COMPLETE THE PROCEDURE. THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN PROCEDURE AND NO ADVERSE PATIENT EFFECTS. NO ADDITIONAL INFORMATION WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 307354 | XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM | DRUG ELUTING CORONARY STENT SYSTEM | NIQ | AV-TEMECULA-CT | 6110741 | 08717648199271 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 78 YR | Other |